Conditions: Friedreich's Ataxia
Keywords: Friedreich's Ataxia Idebenone ICARS
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 68
Healthy volunteers: no

Brief summary:
This study is meant to assess the safety and tolerability of idebenone in patients with Friedreich's Ataxia over a 12 months period.

Detailed description:
The study involves 6 clinic visits.

Arms:
arm 1: high dose Idebenone

Interventions: intervention 1: Idebenone
Intervention descriptions: intervention 1: Patients ≤ 45 kg/99 lbs: idebenone 1350 mg/day; Patients \> 45 kg/99 lbs: idebenone 2250 mg/day

Protocol document: